The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Karmanos Cancer Institute receives $5 million grant from the Dresner Foundation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

THE BARBARA ANN KARMANOS CANCER INSTITUTE received a grant of $5,375,000 from the Dresner Foundation. The grant, focused on hematologic malignancies research, will be distributed over the next five years.

The grant will create an endowed chair position, help recruit scientists and fellowship positions, and establish a patient registry and tissue bank for blood-related cancers.

It will also establish a Patient Assistance Fund to help low-income cancer patients with financial challenges during their cancer care. This grant, combined with the personal giving from the Dresner family, brings their total giving to Karmanos to over $10.4 million since 1998.

Charles Schiffer, multidisciplinary team leader of Malignant Hematology at Karmanos and professor of medicine and oncology at Wayne State University School of Medicine, will serve as the first endowed Joseph Dresner Chair for Hematologic Malignancies.

The Dresner Foundation was established by the late Joseph and Vera Dresner to support health researchers and those dedicated to improving the quality and length of life for patients. Joseph Dresner was diagnosed with MDS in 2002 and was treated by Schiffer at Karmanos.

Table of Contents

YOU MAY BE INTERESTED IN

ClinicalTrials & Tribulations

The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe

Those of us who have devoted our careers to treating recalcitrant cancers know the heartbreak of walking alongside an individual facing an advanced diagnosis. We not only shoulder the clinical responsibility, but also the emotional weight that accompanies every step of that journey as each patient’s story becomes connected to our own.
By W. Kimryn Rathmell

At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
By Sara Willa Ernst, Claire Marie Porter and Paul Goldberg

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 
By Claire Marie Porter
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account